EUVIMEDEUVIMED entdecken
Crossref

Development of a highly sensitive, high-throughput and automated CRISPR-based device for the contamination-free pathogen detection

Hui Ge, Junya Feng, Libing Huang, Zhongqin Luo, Houyu Ling, Li Ma, Miao Wang, Haoxiang Chen, Lei Ren

Biosensors and Bioelectronics · 2025-06 · 278 · 117323

DOI: 10.1016/j.bios.2025.117323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025-06. Verfasst von Hui Ge und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Cultivation and High-value Utilization of Marine Organisms in Fujian Province, Fisheries Research Institute of Fujian, Xiamen, 3610…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Biosensing Techniques, Lab-On-A-Chip Devices. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rapid, portable, and contamination-resistant nucleic acid detection methods are necessary due to the threat posed by emerging viruses to public health and agricultural output. We establish CARE (CRISPR-associated airtight real-time electronic diagnostic device), a novel platform that combines CRISPR-Cas12a with a hermetically sealed microfluidic chip to overcome the limitations of present technologies, which struggle to balance sensitivity, multiplexing, and field applicability. By combining isothermal amplification and CRISPR detection within a hermetically sealed microfluidic chip, CARE eliminates the risk of nucleic acid aerosol contamination while enabling simultaneous high-throughput analysis of seven pathogens. The device is complemented by a user-friendly nucleic acid quantification App, enabling rapid and precise analysis. The RPA-CRISPR/Cas12a system demonstrates exceptional sensitivity, detecting as few as 1 copy μL-1 (single-plex) and 10-102 copies μL-1 (multiplexed), with real-sample performance matching gold-standard methods. CARE represents a significant advancement in CRISPR-based diagnostics, offering a robust, portable solution for on-site pathogen detection in food and agricultural applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsBiosensing TechniquesLab-On-A-Chip DevicesNucleic Acid Amplification TechniquesEquipment DesignHumansLimit of DetectionHigh-Throughput Screening Assays

Stichwörter der Autor:innen

CRISPR/Cas12aDiagnostic deviceMolecular diagnosticNucleic acid detection

Autor:innen und Institutionen

  • Key Laboratory of Cultivation and High-value Utilization of Marine Organisms in Fujian Province, Fisheries Research Institute of Fujian, Xiamen, 361012,China.
  • Key Laboratory of Biomedical Engineering of Fujian Province University/Research Center of Biomedical Engineering of Xiamen, Department of Biomaterials, College of Materials, State Key Laboratory of Vaccines for Infectio…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ge, H., Feng, J., Huang, L., Luo, Z., Ling, H., Ma, L., Wang, M., Chen, H., & Ren, L. (2025). Development of a highly sensitive, high-throughput and automated CRISPR-based device for the contamination-free pathogen detection. Biosensors and Bioelectronics, 278, 117323. https://doi.org/10.1016/j.bios.2025.117323

Vancouver

Ge H, Feng J, Huang L, Luo Z, Ling H, Ma L, et al. Development of a highly sensitive, high-throughput and automated CRISPR-based device for the contamination-free pathogen detection. Biosensors and Bioelectronics. 2025;278:117323. doi:10.1016/j.bios.2025.117323

BibTeX
@article{Ge2025,
  author = {Ge, Hui and Feng, Junya and Huang, Libing and Luo, Zhongqin and Ling, Houyu and Ma, Li and Wang, Miao and Chen, Haoxiang and Ren, Lei},
  title = {Development of a highly sensitive, high-throughput and automated CRISPR-based device for the contamination-free pathogen detection},
  journal = {Biosensors and Bioelectronics},
  year = {2025},
  volume = {278},
  pages = {117323},
  doi = {10.1016/j.bios.2025.117323}
}
Kostenlos starten →